Specifically, AMs derived from patients with COPD exhibited significantly higher MMP9 activity compared to those derived from non-smokers and healthy smokers, with decreased TIMP1 production [72]. The gene discussed is TIMP1; the disease is chronic obstructive pulmonary disease.